Yme1L1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| YME1L1 | |
|---|---|
| Protein Name | YME1 Like 1 ATP-Dependent Protease |
| Gene | YME1L1 |
| UniProt ID | Q8Y333 |
| PDB ID | 5C6B, 5C6C |
| Molecular Weight | 84 kDa |
| Subcellular Localization | Mitochondrial inner membrane |
| Protein Family | AAA+ ATPase family |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
YME1L1 is an ATP-dependent protease belonging to the AAA+ (ATPases Associated with diverse cellular Activities) family. It forms a hexameric complex in the mitochondrial inner membrane. Each subunit contains an N-terminal transmembrane domain that anchors it to the membrane, and a C-terminal ATPase domain with protease activity.
YME1L1 degrades misfolded, oxidized, or damaged proteins in the mitochondrial intermembrane space. It also processes imported precursor proteins and helps maintain mitochondrial proteostasis. YME1L1 is essential for mitochondrial function, particularly under conditions of stress.
Loss of YME1L1 function leads to:
Accumulation of damaged mitochondrial proteins
Mitochondrial dysfunction
Increased sensitivity to apoptosis
Alzheimer's Disease: Mitochondrial proteostasis failure
Parkinson's Disease: Accumulation of damaged mitochondrial proteins
Optic Atrophy: Progressive vision loss
The study of Yme1L1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.